23andMe
PrivateLast Round
M&A
Jul 14, 2025
Est. Valuation
$305M
Total Funding Raised
$1.2B
Company Overview
23andMe is a healthcare technology company that offers direct-to-consumer personal genome services through DNA collection kits, providing users with insights into their genetic ancestry, traits, and health predispositions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, E-commerce, Subscription Commerce
Business Model
B2C
Customer Profile
Hardware Sales, Data as a Service, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
23andMe Comparables
Compare 23andMe with similar companies based on industry and business-model similarity.
23andMe Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Jul 14, 2025 | ||||
| Bankruptcy | Mar 23, 2025 | ||||
| Follow-on Offering | Oct 30, 2023 | ||||
| Follow-on Offering | Jan 18, 2022 | ||||
| M&A | Jun 17, 2021 | ||||
PIPE | Feb 4, 2021 |
23andMe Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Roche Venture Fund | Series C Extension, Series C |
| GV | Series D, Series E, Series C Extension, Series C |
| New Enterprise Associates (NEA) | Series A, Series B, Series D, Series E, Series C Extension, Series C |
| Genentech | Series A |
| Fidelity Management & Research Company | PIPE, M&A, Series F, Series E |
| MPM BioImpact | Series D, Series E, Series C Extension, Series C |
| Mohr Davidow Ventures | Series A |
23andMe Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about 23andMe's valuation, stock price, and market status.